Menu

White Paper

Polyendocrine Metabolic Ovarian Syndrome. Mind The Gap(s): Moving Novel Therapies from Bench to Bedside

This report outlines the current challenges and new opportunities in PCOS drug development. Join the conversation on how we can catalyze collaborative efforts to accelerate the development of evidence-based, mechanism-driven therapies that improve outcomes and quality of life for women living with PCOS.

Download White Paper

Please complete the form below to receive this White Paper

Thank you for becoming part of the movement for change in women's health.

< Back

Thank you for your interest in the White Paper:
“Polyendocrine Metabolic Ovarian Syndrome. Mind The Gap(s): Moving Novel Therapies from Bench to Bedside”.

Download White Paper

Follow us on LinkedIn

First Name is required

Last Name is required

Job Title is required

Company is required

Country is required

Affiliation Type is required

Accept the privacy policy is required

By registering for this white paper, you accept that you may receive direct communication from AWHF.

We will not share your email address with third parties.

Last Insights

Webinar

PMOS Beyond Fertility: A Patient Story

Julia, a mother of three reflects on PMOS/PCOS, fertility treatment, and the overlooked long-term health risks women need to know about.

Webinar

Wiebke Arlt is Rethinking PMOS

Wiebke Arlt discusses how identifying distinct PMOS/PCOS subgroups could unlock more personalised treatment and better metabolic-risk prediction.

Webinar

Gedeon Richter on what is needed for PMOS

In this short video, Thomas Faustmann of Gedeon Richter shares an industry perspective on what is needed to move from symptom management towards disease-modifying therapies for PMOS/PCOS.
Follow us on Social Media
Close